Rowlandmiller & Partners’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$157K	Hold	565	–	–	0.03%	163
2025 Q4	$171K	Hold	565	–	–	0.03%	160
2025 Q3	$158K	Sell	565 -95	-14%	-$25.9K	0.03%	159
2025 Q2	$159K	Sell	660 -8	-1%	-$1.89K	0.03%	155
2025 Q1	$163K	Sell	668 -185	-22%	-$55.7K	0.03%	151
2024 Q4	$280K	Sell	853 -30	-3%	-$10.2K	0.06%	130
2024 Q3	$295K	Sell	883 -95	-10%	-$30.2K	0.06%	130
2024 Q2	$267K	Sell	978 -75	-7%	-$21.8K	0.06%	127
2024 Q1	$364K	Sell	1,053 -18	-2%	-$5.92K	0.08%	119
2023 Q4	$346K	Sell	1,071 -20	-2%	-$6.27K	0.08%	117
2023 Q3	$391K	Sell	1,091 -136	-11%	-$52.5K	0.1%	106
2023 Q2	$465K	Sell	1,227 -235	-16%	-$95.6K	0.11%	105
2023 Q1	$700K	Sell	1,462 -255	-15%	-$119K	0.17%	87
2022 Q4	$725K	Hold	1,717	–	–	0.18%	84
2022 Q3	$716K	Buy	1,717 +65	+4%	+$32.4K	0.19%	78
2022 Q2	$818K	Buy	1,652 +75	+5%	+$39.1K	0.21%	73
2022 Q1	$888K	Buy	1,577 +240	+18%	+$145K	0.21%	74
2021 Q4	$1.01M	Buy	1,337 +674	+102%	+$504K	0.23%	72
2021 Q3	$299K	Sell	663 -674	-50%	-$505K	0.1%	97
2021 Q2	$861K	Buy	1,337 +115	+9%	+$70K	0.21%	79
2021 Q1	$698K	Buy	1,222 +293	+32%	+$174K	0.18%	79
2020 Q4	$542K	Buy	+929	New	+$529K	0.15%	87
2020 Q3	–	Sell	-663	Closed	-$299K	–	143
2020 Q2	$299K	Buy	+663	New	+$293K	0.1%	97